Linking structural, metabolic and functional changes in multiple sclerosis

European Journal of Neurology

Volumn 8, Issue 4, 2001, Pages 291-297

  Filippi, Massimo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Diffusion weighted imaging; Disability; Functional magnetic resonance imaging; Magnetic resonance imaging; Magnetic resonance spectroscopy; Magnetization transfer imaging; Multiple sclerosis

Indexed keywords

CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; GRAY MATTER; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVIEW; WHITE MATTER;

CENTRAL NERVOUS SYSTEM; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 0034957951     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2001.00210.x     Document Type: Review

References (77)

1. Pathology of multiple sclerosis: Progression of the lesion
2. A histological histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis
3. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques
4. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis
5. The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis
6. Detection of ventricular enlargement in patients at the earliest clinical stage of MS
7. The distribution of plaques in the cerebrum in multiple sclerosis
8. Pathologic damage in MS assessed in MS by diffusion weighted and magnetization transfer MRI
9. Magnetisation transfer ratio and mean diffusivity of normal-appearing white and gray matter from patients with multiple sclerosis
10. Mean diffusivity and fractional anisotropy histograms in patients with multiple sclerosis
11. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
12. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
13. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis
14. Chemical pathology of acute demyelinating lesions and its correlation with disability
15. Reversible decreases in N-acetylaspartate after acute brain injury
16. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study
17. Early structural changes in acute MS lesions assessed by serial magnetization transfer studies
18. The role of non-conventional magnetic resonance techniques in monitoring the evolution of multiple sclerosis
19. Magnetization transfer ratio changes in a symptomatic lesion of a patient at presentation with possible multiple sclerosis
20. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis
21. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis
22. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: A follow up study
23. Quantitative assessment of MRI lesion load in multiple sclerosis: A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery
24. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis
25. Magnetization transfer changes in the normal-appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis
26. Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium
27. How does brain MRI lesion Volume change on serial scans in patients with multiple sclerosis?
28. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI
29. A conventional and magnetization transfer MRI study of the cervical cord in patients with multiple sclerosis
30. A quantitative study of water diffusion in MS lesions and normal-appearing white matter using echo-planar imaging
31. Magnetization transfer imaging to monitor the evolution of MS: A one-year follow up study
32. Changes in the normal-appearing brain tissue and cognitive impairment in multiple sclerosis
33. A functional MRI study of the motor system in patients with primary progressive multiple sclerosis
34. Diffusion tensor magnetic resonance imaging in multiple sclerosis
35. Whole brain Volume changes in progressive MS patients treated with cladribine
36. Progressive cerebral atrophy in MS. A serial study using registered, volume tric MRI
37. Imaging of axonal damage of normal-appearing white matter in multiple sclerosis
38. Correlation of magnetization transfer ratio with disability in multiple sclerosis
39. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: Longitudinal quantitative analysis
40. Total brain N-acetylaspartate. A new measure of disease load in MS
41. A serial study of new MS lesions and the white matter from which they arise
42. The prognostic value of MR and MTI findings at presentation in patients with clinically isolated syndromes suggestive of MS
43. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis
44. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis
45. Cortical lesions in multiple sclerosis
46. Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS)
47. Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis
48. The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis
49. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study
50. The neuropathology of multiple sclerosis
51. Correlates of MS disability assessed in-vivo using aggregates of MR quantities
52. Assessment of lesion pathology in multiple sclerosis using MRI morphometry and magnetic resonance spectroscopy
53. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volume try in multiple sclerosis
54. Whole-brain diffusion MR histograms differ between MS subtypes
55. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis
56. Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis
57. A weekly diffusion-weighted imaging study of NAWM in MS
58. Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis
59. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis
60. Cortical/subcortical disease burden and cognitive impairment in multiple sclerosis
61. Diffusion-weighted imaging correlates of cognitive dysfunction in relapsing-remitting multiple sclerosis
62. Relative contributions of brain and cervical cord pathology to MS disability: A study with MTR histogram analysis
63. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
64. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination
65. Serial magnetization transfer imaging to characterize the early evolution of new MS lesions
66. A longitudinal study of brain atrophy in relapsing multiple sclerosis
67. Diagnostic criteria for primary progressive multiple sclerosis: A position paper
68. Spinal cord MRI using multi-array coils and fast spin echo. I. Technical aspects and findings in healthy adults
69. A magnetization transfer histogram study of normal appearing brain tissue in multiple sclerosis
70. Axonal transection in the lesions of multiple sclerosis
71. Accumulation of hypointense lesions ('black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis
72. Quantitative volume tric magnetization transfer analysis in multiple sclerosis: Estimation of macroscopic and microscopic disease burden
73. Correlation of volume tric magnetization transfer imaging with clinical data in MS
74. Patterns of lesion development in multiple sclerosis: Longitudinal observation with T1-weighted spin-echo and magnetization transfer MR
75. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability
76. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis
77. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis